$1,899.00 – $6,599.00
Mekinist in combination with dabrafenib: for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600 gene mutation.
Trametinib as monotherapy: for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600 gene mutation.
Metastatic non-small cell lung cancer with a positive BRAF V600E mutation.
Locally advanced or metastatic anaplastic thyroid cancer with a positive BRAF V600E mutation.
Active ingredient: trametinib dimethyl sulfoxide
Storage temperature 2-8 degrees
Prescription medicine.
| Дозировка | 05 Mg, 2 Mg |
|---|
